RD-Connect, NeurOmics and EURenOmics: Collaborative European initiative for rare diseases

European Journal of Human Genetics

Volumn 26, Issue 6, 2018, Pages 778-785

  Lochmüller, Hanns ^a,b   Badowska, Dorota M ^a   Thompson, Rachel ^a   Knoers, Nine V ^c   Aartsma Rus, Annemieke ^a,d   Gut, Ivo ^e   Wood, Libby ^a   Harmuth, Tina ^f   Durudas, Andre ^g,h   Graessner, Holm ^f   Schaefer, Franz ⁱ  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CENTRE FOR GENOMIC REGULATION CRG   (Spain)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g CMAST Bvba   (Germany)

^h CMAST Bvba   (Belgium)

ⁱ UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

BIOBANK; BIOINFORMATICS; CLINICAL FEATURE; DISEASE REGISTRY; EXON SKIPPING; GENE CONTROL; GENETIC ASSOCIATION; GENOME ANALYSIS; HUMAN; KIDNEY DISEASE; NEUROLOGIC DISEASE; NONHUMAN; OMICS; POPULATION; PREDICTION; PRIORITY JOURNAL; RARE DISEASE; REVIEW; WHOLE GENOME SEQUENCING; GENETICS; GERMANY; INFORMATION DISSEMINATION; INTERNATIONAL COOPERATION; PROTEOMICS; RESEARCH; TRENDS;

BERLIN; HUMANS; INFORMATION DISSEMINATION; INTERNATIONAL COOPERATION; PROTEOMICS; RARE DISEASES; RESEARCH;

EID: 85042563648     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/s41431-018-0115-5     Document Type: Review

References (39)

1. Šimerka P Š. Council recommendation of 8 June 2009 on an action in the field of rare diseases- 2009/C 151/02. Off J Eur Union. 2009;2009:7-10.
2. EURORDIS-Rare Diseases Europe: About Rare Diseases. www. eurordis.org/about-rare-diseases. Accessed 3 Oct 2017
3. Walker CE, Mahede T, Davis G, et al. The collective impact of rare diseases in Western Australia: an estimate using a populationbased cohort. Genet Med. 2017;19:546-52.
4. Austin CP, Cutillo CM, Lau LP, et al. Future of rare diseases research 2017-2027: an IRDiRC perspective. Clin Transl Sci. 2017;11:21-27.
5. Dawkins HJ, Draghia-Akli R, Lasko P. et al. Progress in rare diseases research 2010-2016: an IRDiRC perspective. Clin Transl Sci. 2017;11:11-20.
6. European Commission: Rare diseases, Commission activities in the area of Rare diseases. ec.europa.eu/research/health/index.cfm? pg=area&areaname=rare. Accessed 1 Sep 2017.
7. Girdea M, Dumitriu S, Fiume M, et al. PhenoTips: patient phenotyping software for clinical and research use. Hum Mutat. 2013;34:1057-65.
8. Kohler S, Vasilevsky NA, Engelstad M, et al. The human phenotype ontology in 2017. Nucleic Acids Res. 2017;45:D865-D876
9. Lakiotaki K, Kartsaki E, Kanterakis A, Katsila T, Patrinos GP, Potamias G. ePGA: a web-based information system for translational pharmacogenomics. PLoS One. 2016;11:e0162801
10. Philippakis AA, Azzariti DR, Beltran S, et al. The matchmaker exchange: a platform for rare disease gene discovery. Hum Mutat. 2015;36:915-21.
11. Boycott KM, Rath A, Chong JX, et al. International cooperation to enable the diagnosis of all rare genetic diseases. Am J Hum Genet. 2017;100:695-705.
12. Frederic MY, Lalande M, Boileau C, et al. UMD-predictor, a new prediction tool for nucleotide substitution pathogenicity-application to four genes: FBN1, FBN2, TGFBR1, and TGFBR2. Hum Mutat. 2009;30:952-9.
13. Salgado D, Desvignes JP, Rai G, et al. UMD-predictor: a highthroughput sequencing compliant system for pathogenicity prediction of any human cDNA substitution. Hum Mutat. 2016;37:4
14. Desmet FO, Hamroun D, Lalande M, Collod-Beroud G, Claustres M, Beroud C. Human splicing finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res. 2009;37:e67
15. Wilkinson MD, Dumontier M, Aalbersberg IJ, et al. The FAIR guiding principles for scientific data management and stewardship. Sci Data. 2016;3:160018
16. Gainotti S, Torreri P, Wang CP, et al. The RD-connect registry & biobank finder: a tool for sharing and integrating aggregated data and metadata among rare disease researchers. Eur J Hum Genet. 2017, https://doi.org/10.1038/s41431-017-0085-z.
17. Swertz MA, Jansen RC. Beyond standardization: dynamic software infrastructures for systems biology. Nat Rev Genet. 2007;8:235-43.
18. Swertz MA, Dijkstra M, Adamusiak T, et al. The MOLGENIS toolkit: rapid prototyping of biosoftware at the push of a button. BMC Bioinform. 2010;11 Suppl 12:S12.
19. Mora M, Angelini C, Bignami F, et al. The EuroBioBank Network: 10 years of hands-on experience of collaborative, transnational biobanking for rare diseases. Eur J Hum Genet. 2015;23:1116-23.
20. Mascalzoni D, Dove ES, Rubinstein Y, et al. International charter of principles for sharing bio-specimens and data. Eur J Hum Genet. 2015;23:721-8.
21. Yuille M, van Ommen GJ, Brechot C, et al. Biobanking for Europe. Brief Bioinform. 2008;9:14-24
22. Delli Carri A, Onorati M, Castiglioni V, et al. Human pluripotent stem cell differentiation into authentic striatal projection neurons. Stem Cell Rev. 2013;9:461-74
23. Toonen LJ, Schmidt I, Luijsterburg MS, van Attikum H, van Roon-Mom WM. Antisense oligonucleotide-mediated exon skipping as a strategy to reduce proteolytic cleavage of ataxin-3. Sci Rep. 2016; 6: 35200
24. Miller JR, Lo KK, Andre R, et al. RNA-Seq of Huntington's disease patient myeloid cells reveals innate transcriptional dysregulation associated with proinflammatory pathway activation. Hum Mol Genet. 2016;25:2893-904.
25. Hensman Moss DJ, Flower MD, Lo KK, et al. Huntington's disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer's disease. Sci Rep. 2017;7:44849.
26. Atmaca M, Gulhan B, Korkmaz E, et al. Follow-up results of patients with ADCK4 mutations and the efficacy of CoQ10 treatment. Pediatr Nephrol. 2017;32:1369-75.
27. Lipska BS, Ranchin B, Iatropoulos P, et al. Genotype-phenotype associations in WT1 glomerulopathy. Kidney Int. 2014;85:1169-78.
28. Recker F, Zaniew M, Bockenhauer D, et al. Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome. Pediatr Nephrol. 2015;30:931-43.
29. Trautmann A, Bodria M, Ozaltin F, et al. Spectrum of steroidresistant and congenital nephrotic syndrome in children: the PodoNet registry cohort. Clin J Am Soc Nephrol. 2015;10:592-600
30. Blanchard A, Curis E, Guyon-Roger T, et al. Observations of a large dent disease cohort. Kidney Int. 2016;90:430-9
31. Iatropoulos P, Noris M, Mele C, et al. Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome. Mol Imm 2016 71 131-142
32. Korkmaz E, Lipska-Zietkiewicz BS, Boyer O, et al. ADCK4- associated glomerulopathy causes adolescence-onset FSGS. J Am Soc Nephrol. 2016;27:63-68.
33. Schlingmann KP, Ruminska J, Kaufmann M, et al. Autosomalrecessive mutations in SLC34A1 encoding sodium-phosphate cotransporter 2A cause idiopathic infantile hypercalcemia. J Am Soc Nephrol. 2016;27:604-14.
34. Azukaitis K, Simkova E, Majid MA, et al. The phenotypic spectrum of nephropathies associated with mutations in diacylglycerol kinase epsilon. J Am Soc Nephrol. 2017;28:3066-75.
35. Lipska-Zietkiewicz BS, Gellermann J, Boyer O, et al. Low renal but high extrarenal phenotype variability in Schimke immunoosseous dysplasia. PLoS One. 2017;12:e0180926.
36. Trautmann A, Schnaidt S, Lipska-Zietkiewicz BS, et al. Longterm outcome of steroid-resistant nephrotic syndrome in children. J Am Soc Nephrol. 2017;28:3055-65.
37. Trudu M, Janas S, Lanzani C, et al. Common noncoding UMOD gene variants induce salt-sensitive hypertension and kidney damage by increasing uromodulin expression. Nat Med. 2013;19:1 1655-1660
38. Lochmuller H, Le Cam Y, Jonker AH, et al. ?IRDiRC Recognized Resources': a new mechanism to support scientists to conduct efficient, high-quality research for rare diseases. Eur J Hum Genet. 2017;25:162-5.
39. Lochmuller H, Torrent IFJ, Le Cam Y, et al. The International Rare Diseases Research Consortium: policies and guidelines to maximize impact. Eur J Hum Genet. 2017;25:1293-302